While Spending Thanksgiving Apart, I’ll Hold My Sister in My Heart
It’s the time of year when many of us relish connecting with our families and friends and spending time together to reflect on our blessings. I’m
It’s the time of year when many of us relish connecting with our families and friends and spending time together to reflect on our blessings. I’m
Aiming to improve the clinical outcomes of people with Parkinson’s disease, pharmaceutical company UCB is partnering with key U.K. and U.S.
People with early- or late-onset Parkinson’s disease tend to have different characteristic changes in their speech, according to a new study. The
Cala Health has raised $77 million that will support further innovations of the company’s expertise — bioelectronic medicine — to explore
To heighten awareness and understanding of non-motor Parkinson’s disease symptoms such as hallucinations and delusions, Acadia Pharmaceuticals and
A Swedish group of doctors and researchers are working to develop new tools and models to more effectively manage and treat patients with
Two scientists at Yale University were awarded $2 million from the Michael J. Fox Foundation to conduct the first clinical trial investigating the
The “pause between” is my new Parkinson’s self-management tool. I use it every day to help me switch from old ways of reacting to the
An oral candidate therapy for Parkinson’s disease called GT-02287 lowered the levels of alpha-synuclein accumulation and inflammation, and
Fascinate Therapeutics plans to launch a Phase 2 clinical trial into the safety and early efficacy of KM-819 as a potential therapy
According to a 2013 article in The New York Times, the average American knows about 600 people. Since the debut of “Life, Lemons, and Lemonade”
The American Academy of Neurology (AAN) has issued a new group of guidelines designed to aid clinicians in prescribing the most effective and
Mitochondrial dysfunction in dopamine-producing brain cells is sufficient to cause Parkinson’s disease, according to a new study done in mice. The
My sister Bev, who has stage 3 Parkinson’s disease (PD), was diagnosed in 2017. She currently faces cognitive challenges, including issues with
An interdisciplinary research team from William and Mary University and Virginia Commonwealth University (VCU) are working on artificial intelligence